Matinas BioPharma Holdings MTNB
NYSE MTNB
$0.20 +0.02 (+8.93%)
At close: Aug 21, 2026 · 4:00 PM EDT

Matinas BioPharma Holdings (MTNB) Property, Plant & Equipment (Net) (2013 - 2026)

Matinas BioPharma Holdings (MTNB) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Matinas BioPharma Holdings 1.25 Mn 437,566.66 - -

Historic Data

Download Data
DateValue
Mar 31, 2026 138,000.00
Mar 31, 2026 138,000.00
Dec 31, 2025 138,000.00
Dec 31, 2025 138,000.00
Sep 30, 2025 156,000.00
Sep 30, 2025 156,000.00
Jun 30, 2025 158,000.00
Jun 30, 2025 158,000.00
Mar 31, 2025 450,000.00
Mar 31, 2025 450,000.00
Dec 31, 2024 468,000.00
Dec 31, 2024 468,000.00
Sep 30, 2024 1.65 Mn
Sep 30, 2024 1.65 Mn
Jun 30, 2024 1.74 Mn
Jun 30, 2024 1.74 Mn
Mar 31, 2024 1.83 Mn
Mar 31, 2024 1.83 Mn
Dec 31, 2023 1.92 Mn
Dec 31, 2023 1.92 Mn